Concepedia

Highly expressed EZH2 in combination with BAP1 and MTAP loss, as detected by immunohistochemistry, is useful for differentiating malignant pleural mesothelioma from reactive mesothelial hyperplasia

Masayo Yoshimura, Yoshiaki Kinoshita, Makoto Hamasaki, Shinji Matsumoto, Tomoyuki Hida, Yoshinao Oda, Akinori Iwasaki, Kazuki Nabeshima

Lung Cancer · 2019 · 53 citations · 36 references

DOI

Concepts

References

36

Germline BAP1 mutations predispose to malignant mesothelioma

Joseph R. Testa, Mitchell Cheung, Jianming Pei et al. · Nature Genetics · 2011 · 1.1K citations · Full text

, , +12

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

Matthew J. Bott, Marie Brevet, Barry S. Taylor et al. · Nature Genetics · 2011 · 731 citations

, , +15

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group

Aliya N. Husain, Thomas V. Colby, Nelson G. Ordóǹez et al. · Archives of Pathology & Laboratory Medicine · 2017 · 621 citations · Full text

, , +17

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group

Aliya N. Husain, Thomas V. Colby, Nelson G. Ordóǹez et al. · Archives of Pathology & Laboratory Medicine · 2012 · 465 citations

, , +17

Loss of BAP1 function leads to EZH2-dependent transformation

Lindsay M. LaFave, Wendy Béguelin, Richard P. Koche et al. · Nature Medicine · 2015 · 398 citations · Full text

, , +7